skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines eptinezumabQuestion & answer

eptinezumab · Medicine question

What is the terminal elimination half-life of eptinezumab?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Eptinezumab has a terminal elimination half-life of approximately 27 days.

Sources for this answer

Vyepti 100 mg concentrate for solution for infusion (300 mg not marketed)Lundbeck Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 5Document updated 4 August 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about eptinezumab

What is the shelf life of unopened Vyepti (eptinezumab) concentrate for solution for infusion?Are interactions between eptinezumab and medicines that affect cytochrome P450 enzymes considered likely?Has the effect of eptinezumab on human fertility been evaluated?How does eptinezumab work to prevent migraine attacks?How long can Vyepti (eptinezumab) be kept outside the refrigerator in its original carton at temperatures up to 25°C?How much sorbitol and polysorbate 80 does Vyepti (eptinezumab) concentrate contain per mL?

eptinezumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the eptinezumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX